Neogen Chemicals Q3FY26 Standalone Revenue at ₹215.6 Crore; Profit ₹8.77 Crore
Neogen Chemicals reported standalone Q3FY26 revenue of ₹215.6 crore and profit after tax of ₹8.77 crore. For the nine months, revenue was ₹606.86 crore and profit was ₹32.30 crore. Consolidated Q3FY26 revenue was ₹220.02 crore with profit after tax of ₹3.69 crore. The company continues to assess its insurance claim related to the Dahej plant fire incident.
The decline in profitability, while moderate, coupled with the ongoing resolution of the insurance claim from the fire incident, could impact investor sentiment. The financial results provide a clear picture of the company's performance, and the insurance claim resolution is a significant factor that investors will be watching.
The financial results show a year-on-year decline in profit for both the quarter and nine-month periods, which is a negative indicator. However, revenue has seen modest growth, and the company is actively managing the aftermath of the fire incident, which introduces some uncertainty but also demonstrates proactive management. The overall sentiment is neutral due to mixed financial performance and ongoing recovery efforts.
Neogen Chemicals Limited announced its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. For the quarter, the company reported a revenue from operations of ₹215.60 crore, a slight increase from ₹200.41 crore in the same quarter last year. The profit after tax for the quarter stood at ₹8.77 crore, down from ₹14.41 crore in the corresponding quarter of the previous year. For the nine-month period ended December 31, 2025, revenue from operations was ₹606.86 crore, compared to ₹569.90 crore in the prior-year period. The profit after tax for the nine months was ₹32.30 crore, a decrease from ₹43.21 crore in the same period last year.
The company also provided consolidated financial results. For the quarter ended December 31, 2025, consolidated revenue from operations was ₹220.02 crore, and profit after tax was ₹3.69 crore. For the nine-month period, consolidated revenue was ₹615.40 crore, with a profit after tax of ₹17.33 crore.
The announcement also detailed the company's ongoing assessment of a fire incident at its Dahej SEZ Plant on March 5, 2025. The incident caused damage to property, plant, equipment, and inventory, and interrupted business operations. The company has recognized a loss of ₹348.16 crore and an insurance claim receivable of ₹334.60 crore for the standalone results, presenting a net exceptional item of ₹13.56 crore. For consolidated results, the recognized loss was ₹362.90 crore with an insurance claim of ₹334.82 crore, resulting in a net exceptional item of ₹14.08 crore. The company has received ₹50.00 crore as an on-account payment from the insurance company for the quarter ended June 30, 2025, and ₹30.00 crore for the quarter ended September 30, 2025, and realized ₹3.48 crore from scrap sales. The assessment of the loss claim is in process.
Additionally, the company noted the implementation of new Labour Codes by the Government of India, effective November 21, 2025, which resulted in a minor increase in the provision for defined benefit obligation.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.